Effect of finastride on TUR-P blood loss
Not Applicable
- Conditions
- BPH.Hyperplasia of prostate
- Registration Number
- IRCT2015050922168N1
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
BPH patients who are candidate for TUR-P due to obstructive urinary symptoms
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematocrit. Timepoint: Just before the surgery and 6 hours after. Method of measurement: %.;Tissue microvascular density. Timepoint: After TURP. Method of measurement: The average number of vessels counted in 10 non-overlapping hpf.;Tissue Vascular endothelial growth factor. Timepoint: After TURP. Method of measurement: The average tissue expression of VEGF in specimens.;Surgens satisfaction. Timepoint: After TURP. Method of measurement: based on visual analog scale- 0 to 10.;Removed tissue weight. Timepoint: After TURP. Method of measurement: weight of removed tissue by TURP in gram.;Percent of tissue removed by TURP. Timepoint: After TURP. Method of measurement: weight of tissue removed by TURP devided by total prostate weight.;Total operative time. Timepoint: after TURP. Method of measurement: time from starting TURP until foley fixation- in minutes.
- Secondary Outcome Measures
Name Time Method Short term complications. Timepoint: one week after TURP. Method of measurement: complications that will happen within a week after the surgery.;Long term complications. Timepoint: After one week following TURP. Method of measurement: complications that happens after a week within 3 months after TURP.